Protein-bound Toxin Removal with High-flux Dialyzer in Hemodialysis
ELISIO21HX
Infections
+ Toxemia
Treatment Study
Summary
Study start date: May 1, 2023
Actual date on which the first participant was enrolled.This study focuses on comparing two different kidney dialysis methods to see how well they remove certain toxins from the blood. These toxins are usually bound to proteins or are large molecules, and removing them is important for people with kidney issues. The study aims to understand which method, between hemodialysis and high-volume online hemodiafiltration, is more effective in clearing these toxins. This research is important because finding a more efficient way to clean the blood can improve the health and quality of life for patients undergoing dialysis. Participants in this study will undergo both types of dialysis methods, in a crossover manner, meaning they will switch from one method to the other during the study. The researchers will measure various outcomes, including the reduction of Beta2microglobulin and other specific proteins, as well as checking for any loss of important blood proteins like albumin. Additionally, the study will look at how these treatments affect the patients' quality of life, muscle mass, and nutritional status. Understanding these effects will help in determining the most beneficial dialysis method for patients.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.16 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 90 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorGroup II
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Faculty of Medicine Chulalongkorn university
Pathum Wan, ThailandOpen Faculty of Medicine Chulalongkorn university in Google Maps